Carolina BioOncology Institute Email Format

Biotechnology ResearchNorth Carolina, United States11-50 Employees

Carolina BioOncology Institute (CBOI) is a biotechnology research center specializing in cancer therapy and early-phase immunotherapy trials, headquartered at 9801 Kincey Avenue Suite 145, Huntersville, North Carolina. The organization operates a community-based clinic and positions itself as the only independent, dedicated Phase I cancer center on the East Coast. CBOI has opened more than 100 early-phase clinical trials, treated nearly 4,000 cancer patients, and serves as a regional referral hub for Phase I access in the community setting. Its business model includes BioCytics, an internal research and manufacturing organization focused on rapidly developing cell therapies using novel processes and equipment, supported by integrated capabilities in basic and translational research, process development, cGMP manufacturing, clinical development, regulatory affairs, USP, CLIA/COLA, and operations. Reported annual revenue is in the range of $25 million to $50 million.

Sign up for free to view info

Company overview Employee directory